945400-80-6

Basic information

• Product Name: 6-Benzothiazolamine, 2-bromo-
• Synonyms: 6-Benzothiazolamine, 2-bromo-;2-Bromo-6-benzothiazolamine;2-bromobenzo[d]thiazol-6-amine;2-broMo-1,3-benzothiazol-4-aMine;2-Bromo-6-aminobenzothiazole;2-Bromo-6-aminobenzo[d]thiazole, 97%
• CAS NO: 945400-80-6
• Molecular Formula: C7H5BrN2S
• Molecular Weight: 229.1
• Mol File: 945400-80-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 384.075°C at 760 mmHg
• Flash Point: 186.082°C
• Appearance: /
• Density: 1.837g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.783
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.09±0.10(Predicted)
• CAS DataBase Reference: 6-Benzothiazolamine, 2-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Benzothiazolamine, 2-bromo-(945400-80-6)
• EPA Substance Registry System: 6-Benzothiazolamine, 2-bromo-(945400-80-6)

Safety Data

• Hazardous Substances Data: 945400-80-6(Hazardous Substances Data)

Usage

General Description

6-Benzothiazolamine, 2-bromo- is a chemical compound with the molecular formula C7H5BrNS. It is a yellow to brown crystalline solid that is used as a building block in the synthesis of various organic compounds. It is commonly used in the pharmaceutical and agrochemical industries for the production of drugs and pesticides. Additionally, 6-Benzothiazolamine, 2-bromo- has potential applications in the field of materials science, as it can be used as a precursor for the synthesis of polymers and other advanced materials. This chemical is known to have a moderate level of toxicity and should be handled with care during use and storage.

InChI:InChI=1/C7H5BrN2S/c8-7-10-5-2-1-4(9)3-6(5)11-7/h1-3H,9H2

Upstream product

• 6285-57-0 2-amino-6-nitrobenzothiazole 
• 2516-37-2 2-bromo-6-nitro-benzo[d]thiazole 

Relevant articles and documents

A method of reducing a nitro compound

The present invention relates to a method of reducing a nitro compound, belonging to the field of chemical technology. The method of the present invention comprises, under the condition of adding ferrous halide and reducing agent, the nitro compound undergoes a reduction reaction to prepare an amino compound. The method does not require harsh control conditions such as hydrogen and high pressure, has good tolerance to functional groups such as ester groups, and has no heavy metal residues, which is convenient for implementation and application.

Novel hydrazone derivatives comprising aryl or heteroaryl group substituted at terminal amine and use thereof

The present invention relates to novel hydrazone derivatives with an aryl or heteroaryl group substituted at a terminal amine group thereof and a use thereof.

ANTIVIRAL COMPOUNDS

The present invention discloses compounds of Formula I wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the treatment of HCV infection.